miR-200 enhances mouse breast cancer cell colonization to form distant metastases

Derek M Dykxhoorn, Yichao Wu, Huangming Xie, Fengyan Yu, Ashish Lal, Fabio Petrocca, Denis Martinvalet, Erwei Song, Bing Lim, Judy Lieberman, Derek M Dykxhoorn, Yichao Wu, Huangming Xie, Fengyan Yu, Ashish Lal, Fabio Petrocca, Denis Martinvalet, Erwei Song, Bing Lim, Judy Lieberman

Abstract

Background: The development of metastases involves the dissociation of cells from the primary tumor to penetrate the basement membrane, invade and then exit the vasculature to seed, and colonize distant tissues. The last step, establishment of macroscopic tumors at distant sites, is the least well understood. Four isogenic mouse breast cancer cell lines (67NR, 168FARN, 4TO7, and 4T1) that differ in their ability to metastasize when implanted into the mammary fat pad are used to model the steps of metastasis. Only 4T1 forms macroscopic lung and liver metastases. Because some miRNAs are dysregulated in cancer and affect cellular transformation, tumor formation, and metastasis, we examined whether changes in miRNA expression might explain the differences in metastasis of these cells.

Methodology/principal findings: miRNA expression was analyzed by miRNA microarray and quantitative RT-PCR in isogenic mouse breast cancer cells with distinct metastatic capabilities. 4T1 cells that form macroscopic metastases had elevated expression of miR-200 family miRNAs compared to related cells that invade distant tissues, but are unable to colonize. Moreover, over-expressing miR-200 in 4TO7 cells enabled them to metastasize to lung and liver. These findings are surprising since the miR-200 family was previously shown to promote epithelial characteristics by inhibiting the transcriptional repressor Zeb2 and thereby enhancing E-cadherin expression. We confirmed these findings in these cells. The most metastatic 4T1 cells acquired epithelial properties (high expression of E-cadherin and cytokeratin-18) compared to the less metastatic cells.

Conclusions/significance: Expression of miR-200, which promotes a mesenchymal to epithelial cell transition (MET) by inhibiting Zeb2 expression, unexpectedly enhances macroscopic metastases in mouse breast cancer cell lines. These results suggest that for some tumors, tumor colonization at metastatic sites might be enhanced by MET. Therefore the epithelial nature of a tumor does not predict metastatic outcome.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. MiR-200 family member expression distinguishes…
Figure 1. MiR-200 family member expression distinguishes highly metastatic 4T1 cells from 67NR, 168FARN, and 4TO7 cells.
(A) miRNA microarray analysis of miR-200 family expression in 4 isogenic mouse breast cancer cell lines. The seed sequence (nucleotides 2–7) of the miRNA is underlined. No significant signal was detected for miR-200a and 141 (N.D. = not detected), averaged signal for all samples below 500), but the remaining miR-200 family members were highly expressed in 4T1 cells relative to the less metastatic 67NR, 168FARN, and 4TO7 cells. (B) miR-200 family expression, analyzed by qRT–PCR and normalized to U6 snRNA, confirms the microarray data. miR-23a, which is expressed in all the lines, was analyzed as a control (*, p

Figure 2. Protein expression of Zeb2 protein…

Figure 2. Protein expression of Zeb2 protein negatively correlates and E-cadherin positively correlates with miR-200…

Figure 2. Protein expression of Zeb2 protein negatively correlates and E-cadherin positively correlates with miR-200 expression.
(A) Zeb2 protein, analyzed by immunoblot relative to α-tubulin as a loading control, is significantly lower in 4T1 cells. (B) Zeb2 mRNA, analyzed by qRT-PCR and normalized to Gapdh, is higher in 67NR cells but similarly expressed in the other cell lines. Snail mRNA is somewhat lower in 4T1 cells than the other cell lines. (C–E) E-cadherin protein (C) and mRNA (D) expression is only detected in 4T1 cells, while N-cadherin protein (C) and mRNA (E) is restricted to 67NR cells. Vimentin protein (C) is expressed in all 4 cell lines, but expression is greater in 67NR cells, while vimentin mRNA is expressed at similar levels in all 4 cell lines (F). Cytokeratin-18 (CK-18) mRNA is expressed in 4TO7 and 4T1 cells, while Epidermal Growth Factor Receptor (EGFR) is limited to 4T1 cells (F). Protein was analyzed relative to α-tubulin by immunoblot and mRNA was quantified by qRT-PCR relative to Gapdh. Levels of protein and mRNA for both cadherins changed in parallel. The qRT-PCR results represent the mean and standard deviation from three independent experiments (*p

Figure 3. Over-expression of miR-200 in 4TO7…

Figure 3. Over-expression of miR-200 in 4TO7 cells down-regulates Zeb2 expression, resulting in increased E-cadherin.

Figure 3. Over-expression of miR-200 in 4TO7 cells down-regulates Zeb2 expression, resulting in increased E-cadherin.
(A) Zeb2 expression decreases and E-Cadherin (Cdh1) expression increases, analyzed by immunoblot relative to Gapdh, after transfection of 4TO7 cells with miR-200b and/or miR-200c. (B) miR-200 regulates the Zeb2 3′-UTR in a luciferase reporter assay. 4TO7 cells were co-transfected with the Zeb2 3′-UTR luciferase plasmid or a control vector and either the control (ctl), miR-200b and/or miR-200c miRNA mimics. The mean and standard deviation of the relative luciferase activity, normalized relative to that of mock-transfected cells, from 3 independent experiments is shown (*p

Figure 4. Over-expression of miR-200 in 4TO7…

Figure 4. Over-expression of miR-200 in 4TO7 cells converts fibroblastic cells to an epithelial morphology.

Figure 4. Over-expression of miR-200 in 4TO7 cells converts fibroblastic cells to an epithelial morphology.
(A) Phase contrast microscopy of 4TO7 cells that were either mock treated or transfected with the miRNA control (ctl), miR-200b, or miR-200c mimic. The white bar represents 10 µm. (B) E-cadherin expression visualized by fluorescence microscopy of parental 4T1 and 4TO7 cells (top) and 4TO7 cells that were transfected with miR-200b and/or miR-200c or control mimics (bottom). 4TO7 cells treated with either of the miR-200 mimics adopted an epithelial-like morphology and expressed high levels of E-cadherin, similar to the highly metastatic 4T1 cells. E-cadherin (Cdh1) concentration at the cell-cell junction is shown in the magnified image. Cell nuclei were stained with DAPI.

Figure 5. Stable miR-141-200c over-expression or Zeb2…

Figure 5. Stable miR-141-200c over-expression or Zeb2 silencing in 4TO7 cells promoted adoption of an…

Figure 5. Stable miR-141-200c over-expression or Zeb2 silencing in 4TO7 cells promoted adoption of an epithelial-like morphology.
(A) miR-200c expression is increased in 4TO7 cells stably expressing the miR-141-200c cluster from a retroviral vector. miR-200c levels, normalized to U6 snRNA expression, are shown relative to expression in 4T1 cells. Mean and standard deviation of 3 independent experiments are shown (*, p = 0.02, relative to 4T1 cells). (B) Stable over-expression of the miR-141-200c cluster leads to an increase in E-cadherin expression, as measured by immunoblot relative to α-tubulin. (C) The stable miR-141-200c-expressing 4TO7 cells adopt an epithelial morphology compared to the control transfected cells or the parental cells when examined by phase contrast microscopy. 4TO7 cells stably expressing a Zeb2 shRNA had reduced Zeb2 and concomitantly increased E-cadherin protein by immunoblot (D), and altered morphology from a fibroblastic to an epithelial morphology (E). 4T1 cells are shown for comparison. The white bars represent 10 µm.

Figure 6. miR-200 enhances 4TO7 cells migration…

Figure 6. miR-200 enhances 4TO7 cells migration through a basement membrane, but does not affect…

Figure 6. miR-200 enhances 4TO7 cells migration through a basement membrane, but does not affect cell proliferation.
(A) Exogenous expression of the miR-141-200c cluster (compared to the control vector expressing luciferase shRNA) or Zeb2 shRNA (compared to a luciferase shRNA construct) in 4TO7 cells does not alter colony growth in soft agar. Parental 4TO7 and 4T1 cells also are equally efficient at forming colonies. (B) Cell proliferation as measured by thymidine incorporation is also unaffected in 4TO7 cells expressing miR-200c mimic or Zeb2 siRNA. The mean and standard deviation of 6 independent experiments is shown. (C) Transient over-expression of miR-200b and/or miR-200c enhances the migration of the 4TO7 cells through a basement membrane to the same level as the highly invasive 4T1 cells. The mean and standard deviation from analyzing five fields from triplicate samples is shown (*, p

Figure 7. 4TO7 cells stably over-expressing miR-141-200c…

Figure 7. 4TO7 cells stably over-expressing miR-141-200c form tumors more rapidly that are more likely…

Figure 7. 4TO7 cells stably over-expressing miR-141-200c form tumors more rapidly that are more likely to metastasize.
(A) Primary tumor and metastases is enhanced in 4TO7 cells stably over-expressing the miR-141-200c cluster. The indicated number of cells was injected in the mammary fat pad of female mice (*,p = 0.02; **, p = 0.07; #, p = 0.1; ##, p = 0.005). (B) Growth curves for primary tumors in mice injected with either 5×105 (left) or 1.25×105 cells (right).

Figure 8. Primary tumors and metastases of…

Figure 8. Primary tumors and metastases of 4TO7 cells stably expressing the miR-141-200c cluster express…

Figure 8. Primary tumors and metastases of 4TO7 cells stably expressing the miR-141-200c cluster express E-cadherin.
(A) Representative primary mammary tumors and lung and liver tissue sections stained with hematoxylin and eosin from mice implanted with parental 4T1 and 4TO7 cells or 4TO7 cells stably-expressing miR-141-200c or control vector. 4TO7 cells and 4TO7 cells expressing the control miRNA (miR-ctl) did not form metastases. (B) Primary tumors and lung metastases formed from 4T1 cells and 4TO7 cells transduced with miR-141-200c retrovirus continue to express E-cadherin, while primary tumors from 4TO7 parental cells or 4TO7 cells infected with a control retrovirus remain E-cadherin-. (C) Primary tumors from 3 mice implanted with 4TO7 cells stably expressing miR-141-200c showed high levels of E-cadherin mRNA, analyzed by qRT-PCR and normalized to Gapdh, compared to parental 4TO7 cells. Mean and standard deviation from triplicate samples of each cell line or tumor are shown.
All figures (8)
Similar articles
Cited by
References
    1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. - PubMed
    1. Dykxhoorn DM, Chowdhury D, Lieberman J. RNA interference and cancer: endogenous pathways and therapeutic approaches. Adv Exp Med Biol. 2008;615:299–329. - PubMed
    1. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433:769–773. - PubMed
    1. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102:13944–13949. - PMC - PubMed
    1. Eis PS, Tam W, Sun L, Chadburn A, Li Z, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005;102:3627–3632. - PMC - PubMed
Show all 60 references
Publication types
MeSH terms
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 2. Protein expression of Zeb2 protein…
Figure 2. Protein expression of Zeb2 protein negatively correlates and E-cadherin positively correlates with miR-200 expression.
(A) Zeb2 protein, analyzed by immunoblot relative to α-tubulin as a loading control, is significantly lower in 4T1 cells. (B) Zeb2 mRNA, analyzed by qRT-PCR and normalized to Gapdh, is higher in 67NR cells but similarly expressed in the other cell lines. Snail mRNA is somewhat lower in 4T1 cells than the other cell lines. (C–E) E-cadherin protein (C) and mRNA (D) expression is only detected in 4T1 cells, while N-cadherin protein (C) and mRNA (E) is restricted to 67NR cells. Vimentin protein (C) is expressed in all 4 cell lines, but expression is greater in 67NR cells, while vimentin mRNA is expressed at similar levels in all 4 cell lines (F). Cytokeratin-18 (CK-18) mRNA is expressed in 4TO7 and 4T1 cells, while Epidermal Growth Factor Receptor (EGFR) is limited to 4T1 cells (F). Protein was analyzed relative to α-tubulin by immunoblot and mRNA was quantified by qRT-PCR relative to Gapdh. Levels of protein and mRNA for both cadherins changed in parallel. The qRT-PCR results represent the mean and standard deviation from three independent experiments (*p

Figure 3. Over-expression of miR-200 in 4TO7…

Figure 3. Over-expression of miR-200 in 4TO7 cells down-regulates Zeb2 expression, resulting in increased E-cadherin.

Figure 3. Over-expression of miR-200 in 4TO7 cells down-regulates Zeb2 expression, resulting in increased E-cadherin.
(A) Zeb2 expression decreases and E-Cadherin (Cdh1) expression increases, analyzed by immunoblot relative to Gapdh, after transfection of 4TO7 cells with miR-200b and/or miR-200c. (B) miR-200 regulates the Zeb2 3′-UTR in a luciferase reporter assay. 4TO7 cells were co-transfected with the Zeb2 3′-UTR luciferase plasmid or a control vector and either the control (ctl), miR-200b and/or miR-200c miRNA mimics. The mean and standard deviation of the relative luciferase activity, normalized relative to that of mock-transfected cells, from 3 independent experiments is shown (*p

Figure 4. Over-expression of miR-200 in 4TO7…

Figure 4. Over-expression of miR-200 in 4TO7 cells converts fibroblastic cells to an epithelial morphology.

Figure 4. Over-expression of miR-200 in 4TO7 cells converts fibroblastic cells to an epithelial morphology.
(A) Phase contrast microscopy of 4TO7 cells that were either mock treated or transfected with the miRNA control (ctl), miR-200b, or miR-200c mimic. The white bar represents 10 µm. (B) E-cadherin expression visualized by fluorescence microscopy of parental 4T1 and 4TO7 cells (top) and 4TO7 cells that were transfected with miR-200b and/or miR-200c or control mimics (bottom). 4TO7 cells treated with either of the miR-200 mimics adopted an epithelial-like morphology and expressed high levels of E-cadherin, similar to the highly metastatic 4T1 cells. E-cadherin (Cdh1) concentration at the cell-cell junction is shown in the magnified image. Cell nuclei were stained with DAPI.

Figure 5. Stable miR-141-200c over-expression or Zeb2…

Figure 5. Stable miR-141-200c over-expression or Zeb2 silencing in 4TO7 cells promoted adoption of an…

Figure 5. Stable miR-141-200c over-expression or Zeb2 silencing in 4TO7 cells promoted adoption of an epithelial-like morphology.
(A) miR-200c expression is increased in 4TO7 cells stably expressing the miR-141-200c cluster from a retroviral vector. miR-200c levels, normalized to U6 snRNA expression, are shown relative to expression in 4T1 cells. Mean and standard deviation of 3 independent experiments are shown (*, p = 0.02, relative to 4T1 cells). (B) Stable over-expression of the miR-141-200c cluster leads to an increase in E-cadherin expression, as measured by immunoblot relative to α-tubulin. (C) The stable miR-141-200c-expressing 4TO7 cells adopt an epithelial morphology compared to the control transfected cells or the parental cells when examined by phase contrast microscopy. 4TO7 cells stably expressing a Zeb2 shRNA had reduced Zeb2 and concomitantly increased E-cadherin protein by immunoblot (D), and altered morphology from a fibroblastic to an epithelial morphology (E). 4T1 cells are shown for comparison. The white bars represent 10 µm.

Figure 6. miR-200 enhances 4TO7 cells migration…

Figure 6. miR-200 enhances 4TO7 cells migration through a basement membrane, but does not affect…

Figure 6. miR-200 enhances 4TO7 cells migration through a basement membrane, but does not affect cell proliferation.
(A) Exogenous expression of the miR-141-200c cluster (compared to the control vector expressing luciferase shRNA) or Zeb2 shRNA (compared to a luciferase shRNA construct) in 4TO7 cells does not alter colony growth in soft agar. Parental 4TO7 and 4T1 cells also are equally efficient at forming colonies. (B) Cell proliferation as measured by thymidine incorporation is also unaffected in 4TO7 cells expressing miR-200c mimic or Zeb2 siRNA. The mean and standard deviation of 6 independent experiments is shown. (C) Transient over-expression of miR-200b and/or miR-200c enhances the migration of the 4TO7 cells through a basement membrane to the same level as the highly invasive 4T1 cells. The mean and standard deviation from analyzing five fields from triplicate samples is shown (*, p

Figure 7. 4TO7 cells stably over-expressing miR-141-200c…

Figure 7. 4TO7 cells stably over-expressing miR-141-200c form tumors more rapidly that are more likely…

Figure 7. 4TO7 cells stably over-expressing miR-141-200c form tumors more rapidly that are more likely to metastasize.
(A) Primary tumor and metastases is enhanced in 4TO7 cells stably over-expressing the miR-141-200c cluster. The indicated number of cells was injected in the mammary fat pad of female mice (*,p = 0.02; **, p = 0.07; #, p = 0.1; ##, p = 0.005). (B) Growth curves for primary tumors in mice injected with either 5×105 (left) or 1.25×105 cells (right).

Figure 8. Primary tumors and metastases of…

Figure 8. Primary tumors and metastases of 4TO7 cells stably expressing the miR-141-200c cluster express…

Figure 8. Primary tumors and metastases of 4TO7 cells stably expressing the miR-141-200c cluster express E-cadherin.
(A) Representative primary mammary tumors and lung and liver tissue sections stained with hematoxylin and eosin from mice implanted with parental 4T1 and 4TO7 cells or 4TO7 cells stably-expressing miR-141-200c or control vector. 4TO7 cells and 4TO7 cells expressing the control miRNA (miR-ctl) did not form metastases. (B) Primary tumors and lung metastases formed from 4T1 cells and 4TO7 cells transduced with miR-141-200c retrovirus continue to express E-cadherin, while primary tumors from 4TO7 parental cells or 4TO7 cells infected with a control retrovirus remain E-cadherin-. (C) Primary tumors from 3 mice implanted with 4TO7 cells stably expressing miR-141-200c showed high levels of E-cadherin mRNA, analyzed by qRT-PCR and normalized to Gapdh, compared to parental 4TO7 cells. Mean and standard deviation from triplicate samples of each cell line or tumor are shown.
All figures (8)
Similar articles
Cited by
References
    1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. - PubMed
    1. Dykxhoorn DM, Chowdhury D, Lieberman J. RNA interference and cancer: endogenous pathways and therapeutic approaches. Adv Exp Med Biol. 2008;615:299–329. - PubMed
    1. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433:769–773. - PubMed
    1. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102:13944–13949. - PMC - PubMed
    1. Eis PS, Tam W, Sun L, Chadburn A, Li Z, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005;102:3627–3632. - PMC - PubMed
Show all 60 references
Publication types
MeSH terms
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 3. Over-expression of miR-200 in 4TO7…
Figure 3. Over-expression of miR-200 in 4TO7 cells down-regulates Zeb2 expression, resulting in increased E-cadherin.
(A) Zeb2 expression decreases and E-Cadherin (Cdh1) expression increases, analyzed by immunoblot relative to Gapdh, after transfection of 4TO7 cells with miR-200b and/or miR-200c. (B) miR-200 regulates the Zeb2 3′-UTR in a luciferase reporter assay. 4TO7 cells were co-transfected with the Zeb2 3′-UTR luciferase plasmid or a control vector and either the control (ctl), miR-200b and/or miR-200c miRNA mimics. The mean and standard deviation of the relative luciferase activity, normalized relative to that of mock-transfected cells, from 3 independent experiments is shown (*p

Figure 4. Over-expression of miR-200 in 4TO7…

Figure 4. Over-expression of miR-200 in 4TO7 cells converts fibroblastic cells to an epithelial morphology.

Figure 4. Over-expression of miR-200 in 4TO7 cells converts fibroblastic cells to an epithelial morphology.
(A) Phase contrast microscopy of 4TO7 cells that were either mock treated or transfected with the miRNA control (ctl), miR-200b, or miR-200c mimic. The white bar represents 10 µm. (B) E-cadherin expression visualized by fluorescence microscopy of parental 4T1 and 4TO7 cells (top) and 4TO7 cells that were transfected with miR-200b and/or miR-200c or control mimics (bottom). 4TO7 cells treated with either of the miR-200 mimics adopted an epithelial-like morphology and expressed high levels of E-cadherin, similar to the highly metastatic 4T1 cells. E-cadherin (Cdh1) concentration at the cell-cell junction is shown in the magnified image. Cell nuclei were stained with DAPI.

Figure 5. Stable miR-141-200c over-expression or Zeb2…

Figure 5. Stable miR-141-200c over-expression or Zeb2 silencing in 4TO7 cells promoted adoption of an…

Figure 5. Stable miR-141-200c over-expression or Zeb2 silencing in 4TO7 cells promoted adoption of an epithelial-like morphology.
(A) miR-200c expression is increased in 4TO7 cells stably expressing the miR-141-200c cluster from a retroviral vector. miR-200c levels, normalized to U6 snRNA expression, are shown relative to expression in 4T1 cells. Mean and standard deviation of 3 independent experiments are shown (*, p = 0.02, relative to 4T1 cells). (B) Stable over-expression of the miR-141-200c cluster leads to an increase in E-cadherin expression, as measured by immunoblot relative to α-tubulin. (C) The stable miR-141-200c-expressing 4TO7 cells adopt an epithelial morphology compared to the control transfected cells or the parental cells when examined by phase contrast microscopy. 4TO7 cells stably expressing a Zeb2 shRNA had reduced Zeb2 and concomitantly increased E-cadherin protein by immunoblot (D), and altered morphology from a fibroblastic to an epithelial morphology (E). 4T1 cells are shown for comparison. The white bars represent 10 µm.

Figure 6. miR-200 enhances 4TO7 cells migration…

Figure 6. miR-200 enhances 4TO7 cells migration through a basement membrane, but does not affect…

Figure 6. miR-200 enhances 4TO7 cells migration through a basement membrane, but does not affect cell proliferation.
(A) Exogenous expression of the miR-141-200c cluster (compared to the control vector expressing luciferase shRNA) or Zeb2 shRNA (compared to a luciferase shRNA construct) in 4TO7 cells does not alter colony growth in soft agar. Parental 4TO7 and 4T1 cells also are equally efficient at forming colonies. (B) Cell proliferation as measured by thymidine incorporation is also unaffected in 4TO7 cells expressing miR-200c mimic or Zeb2 siRNA. The mean and standard deviation of 6 independent experiments is shown. (C) Transient over-expression of miR-200b and/or miR-200c enhances the migration of the 4TO7 cells through a basement membrane to the same level as the highly invasive 4T1 cells. The mean and standard deviation from analyzing five fields from triplicate samples is shown (*, p

Figure 7. 4TO7 cells stably over-expressing miR-141-200c…

Figure 7. 4TO7 cells stably over-expressing miR-141-200c form tumors more rapidly that are more likely…

Figure 7. 4TO7 cells stably over-expressing miR-141-200c form tumors more rapidly that are more likely to metastasize.
(A) Primary tumor and metastases is enhanced in 4TO7 cells stably over-expressing the miR-141-200c cluster. The indicated number of cells was injected in the mammary fat pad of female mice (*,p = 0.02; **, p = 0.07; #, p = 0.1; ##, p = 0.005). (B) Growth curves for primary tumors in mice injected with either 5×105 (left) or 1.25×105 cells (right).

Figure 8. Primary tumors and metastases of…

Figure 8. Primary tumors and metastases of 4TO7 cells stably expressing the miR-141-200c cluster express…

Figure 8. Primary tumors and metastases of 4TO7 cells stably expressing the miR-141-200c cluster express E-cadherin.
(A) Representative primary mammary tumors and lung and liver tissue sections stained with hematoxylin and eosin from mice implanted with parental 4T1 and 4TO7 cells or 4TO7 cells stably-expressing miR-141-200c or control vector. 4TO7 cells and 4TO7 cells expressing the control miRNA (miR-ctl) did not form metastases. (B) Primary tumors and lung metastases formed from 4T1 cells and 4TO7 cells transduced with miR-141-200c retrovirus continue to express E-cadherin, while primary tumors from 4TO7 parental cells or 4TO7 cells infected with a control retrovirus remain E-cadherin-. (C) Primary tumors from 3 mice implanted with 4TO7 cells stably expressing miR-141-200c showed high levels of E-cadherin mRNA, analyzed by qRT-PCR and normalized to Gapdh, compared to parental 4TO7 cells. Mean and standard deviation from triplicate samples of each cell line or tumor are shown.
All figures (8)
Similar articles
Cited by
References
    1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. - PubMed
    1. Dykxhoorn DM, Chowdhury D, Lieberman J. RNA interference and cancer: endogenous pathways and therapeutic approaches. Adv Exp Med Biol. 2008;615:299–329. - PubMed
    1. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433:769–773. - PubMed
    1. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102:13944–13949. - PMC - PubMed
    1. Eis PS, Tam W, Sun L, Chadburn A, Li Z, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005;102:3627–3632. - PMC - PubMed
Show all 60 references
Publication types
MeSH terms
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 4. Over-expression of miR-200 in 4TO7…
Figure 4. Over-expression of miR-200 in 4TO7 cells converts fibroblastic cells to an epithelial morphology.
(A) Phase contrast microscopy of 4TO7 cells that were either mock treated or transfected with the miRNA control (ctl), miR-200b, or miR-200c mimic. The white bar represents 10 µm. (B) E-cadherin expression visualized by fluorescence microscopy of parental 4T1 and 4TO7 cells (top) and 4TO7 cells that were transfected with miR-200b and/or miR-200c or control mimics (bottom). 4TO7 cells treated with either of the miR-200 mimics adopted an epithelial-like morphology and expressed high levels of E-cadherin, similar to the highly metastatic 4T1 cells. E-cadherin (Cdh1) concentration at the cell-cell junction is shown in the magnified image. Cell nuclei were stained with DAPI.
Figure 5. Stable miR-141-200c over-expression or Zeb2…
Figure 5. Stable miR-141-200c over-expression or Zeb2 silencing in 4TO7 cells promoted adoption of an epithelial-like morphology.
(A) miR-200c expression is increased in 4TO7 cells stably expressing the miR-141-200c cluster from a retroviral vector. miR-200c levels, normalized to U6 snRNA expression, are shown relative to expression in 4T1 cells. Mean and standard deviation of 3 independent experiments are shown (*, p = 0.02, relative to 4T1 cells). (B) Stable over-expression of the miR-141-200c cluster leads to an increase in E-cadherin expression, as measured by immunoblot relative to α-tubulin. (C) The stable miR-141-200c-expressing 4TO7 cells adopt an epithelial morphology compared to the control transfected cells or the parental cells when examined by phase contrast microscopy. 4TO7 cells stably expressing a Zeb2 shRNA had reduced Zeb2 and concomitantly increased E-cadherin protein by immunoblot (D), and altered morphology from a fibroblastic to an epithelial morphology (E). 4T1 cells are shown for comparison. The white bars represent 10 µm.
Figure 6. miR-200 enhances 4TO7 cells migration…
Figure 6. miR-200 enhances 4TO7 cells migration through a basement membrane, but does not affect cell proliferation.
(A) Exogenous expression of the miR-141-200c cluster (compared to the control vector expressing luciferase shRNA) or Zeb2 shRNA (compared to a luciferase shRNA construct) in 4TO7 cells does not alter colony growth in soft agar. Parental 4TO7 and 4T1 cells also are equally efficient at forming colonies. (B) Cell proliferation as measured by thymidine incorporation is also unaffected in 4TO7 cells expressing miR-200c mimic or Zeb2 siRNA. The mean and standard deviation of 6 independent experiments is shown. (C) Transient over-expression of miR-200b and/or miR-200c enhances the migration of the 4TO7 cells through a basement membrane to the same level as the highly invasive 4T1 cells. The mean and standard deviation from analyzing five fields from triplicate samples is shown (*, p

Figure 7. 4TO7 cells stably over-expressing miR-141-200c…

Figure 7. 4TO7 cells stably over-expressing miR-141-200c form tumors more rapidly that are more likely…

Figure 7. 4TO7 cells stably over-expressing miR-141-200c form tumors more rapidly that are more likely to metastasize.
(A) Primary tumor and metastases is enhanced in 4TO7 cells stably over-expressing the miR-141-200c cluster. The indicated number of cells was injected in the mammary fat pad of female mice (*,p = 0.02; **, p = 0.07; #, p = 0.1; ##, p = 0.005). (B) Growth curves for primary tumors in mice injected with either 5×105 (left) or 1.25×105 cells (right).

Figure 8. Primary tumors and metastases of…

Figure 8. Primary tumors and metastases of 4TO7 cells stably expressing the miR-141-200c cluster express…

Figure 8. Primary tumors and metastases of 4TO7 cells stably expressing the miR-141-200c cluster express E-cadherin.
(A) Representative primary mammary tumors and lung and liver tissue sections stained with hematoxylin and eosin from mice implanted with parental 4T1 and 4TO7 cells or 4TO7 cells stably-expressing miR-141-200c or control vector. 4TO7 cells and 4TO7 cells expressing the control miRNA (miR-ctl) did not form metastases. (B) Primary tumors and lung metastases formed from 4T1 cells and 4TO7 cells transduced with miR-141-200c retrovirus continue to express E-cadherin, while primary tumors from 4TO7 parental cells or 4TO7 cells infected with a control retrovirus remain E-cadherin-. (C) Primary tumors from 3 mice implanted with 4TO7 cells stably expressing miR-141-200c showed high levels of E-cadherin mRNA, analyzed by qRT-PCR and normalized to Gapdh, compared to parental 4TO7 cells. Mean and standard deviation from triplicate samples of each cell line or tumor are shown.
All figures (8)
Figure 7. 4TO7 cells stably over-expressing miR-141-200c…
Figure 7. 4TO7 cells stably over-expressing miR-141-200c form tumors more rapidly that are more likely to metastasize.
(A) Primary tumor and metastases is enhanced in 4TO7 cells stably over-expressing the miR-141-200c cluster. The indicated number of cells was injected in the mammary fat pad of female mice (*,p = 0.02; **, p = 0.07; #, p = 0.1; ##, p = 0.005). (B) Growth curves for primary tumors in mice injected with either 5×105 (left) or 1.25×105 cells (right).
Figure 8. Primary tumors and metastases of…
Figure 8. Primary tumors and metastases of 4TO7 cells stably expressing the miR-141-200c cluster express E-cadherin.
(A) Representative primary mammary tumors and lung and liver tissue sections stained with hematoxylin and eosin from mice implanted with parental 4T1 and 4TO7 cells or 4TO7 cells stably-expressing miR-141-200c or control vector. 4TO7 cells and 4TO7 cells expressing the control miRNA (miR-ctl) did not form metastases. (B) Primary tumors and lung metastases formed from 4T1 cells and 4TO7 cells transduced with miR-141-200c retrovirus continue to express E-cadherin, while primary tumors from 4TO7 parental cells or 4TO7 cells infected with a control retrovirus remain E-cadherin-. (C) Primary tumors from 3 mice implanted with 4TO7 cells stably expressing miR-141-200c showed high levels of E-cadherin mRNA, analyzed by qRT-PCR and normalized to Gapdh, compared to parental 4TO7 cells. Mean and standard deviation from triplicate samples of each cell line or tumor are shown.

References

    1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
    1. Dykxhoorn DM, Chowdhury D, Lieberman J. RNA interference and cancer: endogenous pathways and therapeutic approaches. Adv Exp Med Biol. 2008;615:299–329.
    1. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433:769–773.
    1. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102:13944–13949.
    1. Eis PS, Tam W, Sun L, Chadburn A, Li Z, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005;102:3627–3632.
    1. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol. 2005;207:243–249.
    1. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008;27:2128–2136.
    1. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65:7065–7070.
    1. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65:6029–6033.
    1. Zhu S, Wu H, Wu F, Nie D, Sheng S, et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008;18:350–359.
    1. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449:682–688.
    1. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A. 2009;106:1814–1819.
    1. Gebeshuber CA, Zatloukal K, Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 2009
    1. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451:147–152.
    1. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007;131:1109–1123.
    1. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med. 2007;58:267–284.
    1. Dalerba P, Clarke MF. Cancer stem cells and tumor metastasis: first steps into uncharted territory. Cell Stem Cell. 2007;1:241–242.
    1. Wicha MS. Cancer stem cells and metastasis: lethal seeds. Clin Cancer Res. 2006;12:5606–5607.
    1. Al-Hajj M. Cancer stem cells and oncology therapeutics. Curr Opin Oncol. 2007;19:61–64.
    1. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. Cancer stem cells–perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006;66:9339–9344.
    1. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442–454.
    1. Berx G, Raspe E, Christofori G, Thiery JP, Sleeman JP. Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis. 2007;24:587–597.
    1. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499–507.
    1. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449:557–563.
    1. Baum B, Settleman J, Quinlan MP. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol. 2008;19:294–308.
    1. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415–428.
    1. Moreno-Bueno G, Cubillo E, Sarrio D, Peinado H, Rodriguez-Pinilla SM, et al. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 2006;66:9543–9556.
    1. Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis. 2008;25:621–628.
    1. Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992;52:1399–1405.
    1. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008;68:7846–7854.
    1. Gregory PA, Bracken CP, Bert AG, Goodall GJ. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle. 2008;7:3112–3118.
    1. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10:593–601.
    1. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008;9:582–589.
    1. Parker C, Rampaul RS, Pinder SE, Bell JA, Wencyk PM, et al. E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer. 2001;85:1958–1963.
    1. Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283:14910–14914.
    1. Hurteau GJ, Carlson JA, Spivack SD, Brock GJ. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007;67:7972–7976.
    1. Peter ME. Let-7 and miR-200 microRNAs: Guardians against pluripotency and cancer progression. Cell Cycle. 2009;8
    1. Liu G, Min H, Yue S, Chen CZ. Pre-miRNA loop nucleotides control the distinct activities of mir-181a-1 and mir-181c in early T cell development. PLoS ONE. 2008;3:e3592. doi: .
    1. Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129:705–733.
    1. Hashizume R, Koizumi H, Ihara A, Ohta T, Uchikoshi T. Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. Histopathology. 1996;29:139–146.
    1. Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, et al. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. J Pathol. 1999;187:523–529.
    1. Lipponen P, Saarelainen E, Ji H, Aaltomaa S, Syrjanen K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol. 1994;174:101–109.
    1. Kartenbeck J, Haselmann U, Gassler N. Synthesis of junctional proteins in metastasizing colon cancer cells. Eur J Cell Biol. 2005;84:417–430.
    1. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer. 1996;69:184–189.
    1. Chaffer CL, Dopheide B, McCulloch DR, Lee AB, Moseley JM, et al. Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Metastasis. 2005;22:115–125.
    1. Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, et al. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res. 2006;66:11271–11278.
    1. Bracken CP, Gregory PA, Khew-Goodall Y, Goodall GJ. The role of microRNAs in metastasis and epithelial-mesenchymal transition. Cell Mol Life Sci 2009
    1. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol. 2008;10:202–210.
    1. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008;14:2348–2360.
    1. Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, et al. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 2009
    1. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, et al. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007;67:8699–8707.
    1. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, et al. MicroRNA Expression Profiles in Serous Ovarian Carcinoma. Clin Cancer Res. 2008;14:2690–2695.
    1. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A. 2006;103:9136–9141.
    1. Kim SW, Kim JW, Kim YT, Kim JH, Kim S, et al. Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease. Genes Chromosomes Cancer. 2007;46:1–9.
    1. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 2006;130:2113–2129.
    1. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92–105.
    1. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494–498.
    1. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet. 2003;33:401–406.
    1. Chang K, Elledge SJ, Hannon GJ. Lessons from Nature: microRNA-based shRNA libraries. Nat Methods. 2006;3:707–714.
    1. Shi SR, Chaiwun B, Young L, Cote RJ, Taylor CR. Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem. 1993;41:1599–1604.

Source: PubMed

3
Subscribe